THU248 Screening For Heart Failure In Patients With Diabetes Mellitus - A SwissDiab Study

Disclosure: M. Brandle: None. L. Knaus: None. M. Quarella: None. M. Maeder: None. M. Buser: None. F. Renstrom: None. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been shown to significantly reduce the risk of hospitalization for heart failure (HF) and death from cardiovascular causes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandle, Michael, Knaus, Laura, Quarella, Marino, Maeder, Micha, Buser, Marc, Renstrom, Frida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554707/
http://dx.doi.org/10.1210/jendso/bvad114.685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554707/
http://dx.doi.org/10.1210/jendso/bvad114.685

Ejemplares similares